Genasys Inc. (NASDAQ: GNSS) extends $15.2M term loan, adds 20% MOIC and $1M payments
Rhea-AI Filing Summary
Genasys Inc. amended its Term Loan and Security Agreement, extending the outstanding $15,206,812.50 Closing Date Term Loan maturity from July 13, 2026 to July 13, 2027. The regular interest rate remains three-month SOFR plus 5%, but the loan is now subject to a guaranteed minimum return (MOIC) of 20%.
Beginning October 1, 2026, Genasys must make monthly payments of $1 million, each including principal and related MOIC, with the default rate raised to 5% above the otherwise applicable per annum rate. The agreement includes a $4 million minimum liquidity covenant and restrictions on distributions, investments, indebtedness, asset sales, loans, and certain payments. A related warrant amendment extends the warrant exercise period from May 13, 2029 to May 13, 2030 and reduces the exercise price from $2.53 to $2.28 per share. Genasys cites a strong backlog and growing pipeline and expresses confidence in meeting these obligations while funding growth.
Positive
- Extension of term loan maturity to July 13, 2027 replaces a nearer 2026 due date, giving Genasys more time to service its $15.2 million obligation.
- Amending warrants to lower the exercise price to $2.28 and extend expiry to May 13, 2030 could make potential equity financing more attainable.
Negative
- The term loan now carries a guaranteed minimum return (MOIC) of 20%, increasing the overall economic cost of the debt to Genasys.
- Mandatory $1 million monthly payments starting October 1, 2026, plus a $4 million minimum liquidity covenant, may pressure near-term cash flows.
Insights
Analyzing...
8-K Event Classification
Key Figures
Key Terms
Term Loan and Security Agreement financial
guaranteed minimum return financial
MOIC financial
minimum liquidity covenant financial
Protective Communications technical
Long Range Acoustic Device technical
FAQ
What did Genasys Inc. (GNSS) announce regarding its term loan?
How much principal is outstanding on Genasys Inc. (GNSS) term loan?
When do Genasys Inc. (GNSS) new monthly loan payments begin and how much are they?
What is the new maturity date and interest structure of GNSS’s term loan?
What covenants apply to the amended Genasys Inc. (GNSS) term loan?
What changes were made to Genasys Inc. (GNSS) warrants in the amendment?
How does Genasys Inc. (GNSS) describe its ability to meet the amended loan obligations?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On July 13, 2026 (the “Effective Date”), Genasys Inc. (the “Company”) entered into, and closed on, a Third Amendment to Term Loan and Security Agreement (the “Third Amendment”) among the Company, Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders from time to time party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent, to amend that certain Term Loan and Security Agreement entered into among such parties on May 13, 2024 (as amended, the “Term Loan Agreement”). On the Effective Date, the principal amount outstanding under the Term Loan Agreement, all of which relates to the Closing Date Term Loan (as defined in such agreement), was $15,206,812.50.
Under the Third Amendment, among other things, (i) the maturity date of the Closing Date Term Loan is extended from July 13, 2026 to July 13, 2027; (ii) the regular interest rate applicable to the Closing Date Term Loan will remain at three-month SOFR plus 5%; however, the Closing Date Term Loan will also be subject to a guaranteed minimum return of 20% (the “MOIC”); (iii) the Company is obligated to make monthly payments on the Closing Date Term Loan of $1 million beginning on October 1, 2026, which will include repayment of principal and the MOIC thereon; and (iv) the default interest rate is raised to 5% above the per annum rate otherwise applicable. In connection with the Third Amendment, on the Effective Date, the Company entered into an amendment (the “Warrant Amendment”) to the Warrant Agreement, dated as of May 13, 2024, by and between the Company and its warrant agent to extend the exercise period of the warrants issued thereunder from May 13, 2029 to May 13, 2030 and to reduce the exercise price of the warrants from $2.53 per share to $2.28 per share.
The Third Amendment and the Term Loan Agreement contain customary representations and warranties of the Company, affirmative and negative covenants (including, without limitation, a $4 million minimum liquidity covenant, as well as covenants restricting the Company from certain distributions, investments, indebtedness, sales of assets, loans, and payments), events of default and remedies thereupon, indemnification obligations of the Company, termination provisions, and other obligations and rights of the parties.
The foregoing descriptions of the Third Amendment and Warrant Amendment are qualified by reference to the full text of the Third Amendment and Warrant Amendment, respectively, which are filed as Exhibits 10.1 and 10.2 hereto, respectively, and incorporated herein by reference. The Third Amendment has been included to provide investors with information regarding its terms. The representations, warranties and covenants contained in the Third Amendment were made only for purposes of the Third Amendment and as of specific dates, were solely for the benefit of the parties to the Third Amendment, are subject to limitations agreed upon by the parties thereto, and should not be relied upon by investors.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The disclosure set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 3.02 Unregistered Sales of Equity Securities.
The disclosure set forth in Item 1.01 of this Current Report on Form 8-K and in Item 3.02 of the Company’s Current Report on Form 8-K filed on May 14, 2024 is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On July 15, 2026, the Company issued a press release in connection with the transaction, which is attached hereto as Exhibit 99.1.
The information furnished in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
|
|
|
10.1 |
|
Third Amendment to Term Loan and Security Agreement, dated July 13, 2026, among Genasys Inc., Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent. |
|
|
|
10.2 |
|
First Amendment to Warrant Agreement, dated July 13, 2026, by and among Genasys, Inc., Equiniti Trust Company, LLC, as successor to Issuer Direct Corporation, and the holders party thereto. |
|
|
|
99.1 |
|
Press Release, dated July 15, 2026. |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Genasys Inc. |
|
|
|
|
Date: |
July 15, 2026 |
By: |
/s/ Cassandra L. Hernandez-Monteon |
|
|
|
Cassandra L. Hernandez-Monteon |
Genasys Extends Term Loan Maturity to July 2027
Amendment provides working capital flexibility to support strong backlog and continued growth
SAN DIEGO, CA – July 15, 2026 – Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications®, today announced that the Company has entered into and closed a Third Amendment (the “Third Amendment”) to the Company’s Term Loan and Security Agreement (the “Term Loan Agreement”).
Under the Third Amendment, the maturity date of the term loan, which has an initial principal amount of $15.2 million, has been extended to July 13, 2027, with the interest rate maintained at three-month SOFR plus 5%. The Third Amendment is subject to additional terms, conditions and incentives, including a guaranteed minimum rate of return (“MOIC”) of 20% and requires the Company, beginning October 1, 2026, to make monthly payments of $1.0 million towards amortization of the term loan, with each such payment including the MOIC on the principal repaid.
The amended structure replaces quarterly interest payments and a single balloon payment at maturity with scheduled monthly payments, allowing the Company to retire the debt gradually from operating cash flow while preserving liquidity throughout the term. Backed by a strong backlog and growing pipeline, the Company is confident in its ability to satisfy the full obligations of the Term Loan Agreement over the next 12 months.
“The Third Amendment to our Term Loan Agreement provides the Company with the financial flexibility to fund growth and service our expanding customer base,” said Richard Danforth, Genasys’ Chief Executive Officer. “We continue to see strong demand for both our hardware and software offerings, and the Third Amendment enables us to stay focused on serving existing customers while pursuing new ones without working capital constraints tied to the timing of customer payments. Our lender's continued partnership reflects confidence in Genasys' trajectory, backlog, and pipeline, and positions us to convert that momentum into long-term shareholder value – we thank them for their continued confidence.”
Full details of the loan and any additional terms can be found in the Form 8-K the Company filed with the SEC today.
About Genasys Inc.
Genasys is the global leader in Protective Communications®, providing the most comprehensive portfolio of preparedness, response, and analytics software and hardware solutions available. The company’s Long Range Acoustic Device® (LRAD®) and Protect Platform, which includes Genasys Protect® and Genasys Evertel®, are designed around one premise: ensuring organizations and public safety agencies are Ready when it matters®. Protecting people and saving lives for over 40 years, Genasys covers more than 155 million people in all 50 states and in over 100 countries worldwide. For more information, visit genasys.com.
Forward-Looking Statements
Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and uncertainties in these forward-looking statements include without limitation risks relating to continuous delays in receiving payment under, regulatory uncertainties surrounding, or disruptions in governmental support or funding of, the Puerto Rico project, our reliance on a limited number of customers, the likely need for additional capital, actual or perceived failures or breaches of our information and security systems, the effects of continued geopolitical unrest and regional conflicts, including the conflict in Iran and its effect on global oil supply and prices, continued funding of government spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, competition, changes in technology and methods of marketing, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, market acceptance of the Company’s products, shortages in components or price increases that cannot be passed on
to customers, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, difficulties in retaining key employees and customers, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management’s expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding potential risks and uncertainties, see the “Risk Factors” section of the Company’s Form 10-K for the fiscal year ended September 30, 2025. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise specifically stated.
Investor Relations Contact
Scott Liolios and Clay Liolios
Gateway Group, Inc.
949-574-3860
GNSS@gateway-grp.com